ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
0.00%
(0.00) Siku 1
13 Nov, 17:35:01 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Trefis
·
saa 2 zilizopita
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
saa 12 zilizopita
How much of the S&P 500 is Nvidia? Concentration explained
Advisor Perspectives
·
dakika 26 zilizopita
S&P 500 Snapshot: Stocks Up 2.5% to Log Best Week Since August
Traders Union
·
saa 19 zilizopita
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com